Get started
Author

Huajia Zhang

Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone
2015 · Xiaolin Tu, Jesus Delgado-Calle, et al. · Proceedings of the National Academy of Sciences · 278
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
2019 · Julia Kargl, Xiaodong Zhu, et al. · JCI Insight · 190
Notch-Dependent Repression of miR-155 in the Bone Marrow Niche Regulates Hematopoiesis in an NF-κB-Dependent Manner
2014 · Lin Wang, Huajia Zhang, et al. · Cell stem cell · 186
PDF
Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non–Small Cell Lung Cancer
2017 · Nicholas M. Mark, Julia Kargl, et al. · American Journal of Respiratory and Critical Care Medicine · 131
Sepsis Induces Hematopoietic Stem Cell Exhaustion and Myelosuppression through Distinct Contributions of TRIF and MYD88
2016 · Huajia Zhang, Sonia Rodriguez, et al. · Stem Cell Reports · 118
PDF
MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity
2020 · Eli Grunblatt, Nan Wu, et al. · Genes & Development · 95
PDF
CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche
2014 · Brahmananda Reddy Chitteti, Michihiro Kobayashi, et al. · Blood · 67
Annexin A2/TLR2/MYD88 pathway induces arginase 1 expression in tumor-associated neutrophils
2022 · Huajia Zhang, Xiaodong Zhu, et al. · Journal of Clinical Investigation · 65
PDF
Anti–PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma
2019 · Chibawanye I Ene, Shannon A Kreuser, et al. · Neuro-Oncology · 55
PDF
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL
2019 · Sonia Rodriguez, Christina Abundis, et al. · Leukemia · 40
PDF
Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma
2019 · Hans-Georg Wirsching, Huajia Zhang, et al. · JCI Insight · 32
PDF
Good cops turn bad: The contribution of neutrophils to immune-checkpoint inhibitor treatment failures in cancer
2020 · Huajia Zhang, A. McGarry Houghton · Pharmacology & Therapeutics · 20
Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9
2019 · Hans-Georg Wirsching, Sonali Arora, et al. · Neuro-Oncology · 12
PDF
Hierarchical Clustering of Lung Cancer Related Genes
2008 · Wei Yu, Huajia Zhang, et al. · International Conference on Bioinformatics and Biomedical Engineering · 3
Abstract 3588: Discovery of potent and selective CSNK1A1 inhibitors for solid tumor therapy
2022 · Steven M. Corsello, Huajia Zhang, et al. · Cancer Research · 1
SKP2 Is Dispensable for Normal T-Cell Development but Required for T-Cell Leukemogenesis
2014 · Sonia Rodriguez-Rodriguez, Lin Wang, et al. · Blood · 1
Figure S16 from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Data from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Figure S10 from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Figure S1 from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Figure S18 from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Figure S3 from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Figure S15 from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Figure S12 from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Tables S1-S6 from Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity
2026 · Daniel R. Lu, Tao Osgood, et al.
Works count: 49
Citation count: 1,293
H-index: 12
I10-index: 13
Year
Topic
Type